The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms

[1]  Alan C. Evans,et al.  The Effects of an APOE Promoter Polymorphism on Human Cortical Morphology during Nondemented Aging , 2015, The Journal of Neuroscience.

[2]  D. Ryglewicz,et al.  Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI. , 2013, Current Alzheimer research.

[3]  J T O'Brien,et al.  EFNS guidelines for the diagnosis and management of Alzheimer’s disease , 2010, European journal of neurology.

[4]  Christina Brahe,et al.  The complex interaction between APOE promoter and AD: an Italian case–control study , 2009, European Journal of Human Genetics.

[5]  M. Gill,et al.  Apolipoprotein E promoter polymorphisms (−491A/T and −427T/C) and Alzheimer’s disease: no evidence of association in the Irish population , 2008, Irish journal of medical science.

[6]  Philippe Amouyel,et al.  Genetic heterogeneity of Alzheimer's disease: Complexity and advances , 2007, Psychoneuroendocrinology.

[7]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[8]  J. Gilbert,et al.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease , 2004, Neurogenetics.

[9]  J. Lambert,et al.  APOE promoter polymorphisms and dementia in the elderly , 2004, Neuroscience Letters.

[10]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[11]  D. Clair,et al.  Apolipoprotein E −491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population , 2003, Neuroscience Letters.

[12]  J. Yunis,et al.  Haplogroup analysis of the risk associated with APOE promoter polymorphisms (−219T/G, −491A/T and −427T/C) in Colombian Alzheimer's disease patients , 2003, Neuroscience Letters.

[13]  Simon M Laws,et al.  Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription , 2003, Journal of neurochemistry.

[14]  D. Hernandez,et al.  Contribution of APOE promoter polymorphisms to Alzheimer’s disease risk , 2002, Neurology.

[15]  J. Mate,et al.  The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset , 2002, Neuroscience Letters.

[16]  O. Combarros,et al.  The −491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease , 2001, Neuroscience Letters.

[17]  D. Campion,et al.  APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population , 2000, European Journal of Human Genetics.

[18]  M. Franceschi,et al.  APOE −491 promoter polymorphism is a risk factor for late-onset Alzheimer’s disease , 1999, Neurology.

[19]  H. Soininen,et al.  Promoter polymorphism (–491A/T) in the APOE gene of Finnish Alzheimer’s disease patients and control individuals , 1999, Journal of Neurology.

[20]  I. Wiechmann,et al.  Genetic variability of apolipoprotein E in a Polish population. , 1998, Human biology.

[21]  A. Goate,et al.  Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. , 1998, Human molecular genetics.

[22]  M. Gold,et al.  The −491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism , 1998, Neuroscience Letters.

[23]  M. Bullido,et al.  Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene , 1998, FEBS letters.

[24]  C. Franceschi,et al.  An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[25]  H. Arai,et al.  No evidence of association between apolipoprotein E gene regulatory region polymorphism and Alzheimer's disease in Japanese , 2000, Journal of Neural Transmission.

[26]  J. Morris,et al.  A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia , 1998, Nature Genetics.